PURPOSE. The production of proinflammatory cytokines and chemokines as well as the surface expression of intercellular adhesion molecule ( ICAM)-1 by corneal fibroblasts contribute to corneal inflammation. The effects of triptolide on the expression of these proteins induced by lipopolysaccharide ( LPS) in human corneal fibroblasts were examined in comparison with those of dexamethasone. METHODS. The release of interleukin ( IL)-1 beta, tumor necrosis factor ( TNF)-alpha, IL-6, granulocyte colony-stimulating factor ( GCSF), granulocyte-macrophage colony-stimulating factor ( GMCSF), monocyte chemotactic protein ( MCP)-1, macrophage inflammatory protein ( MIP)-1 beta, and IL-8 from cultured corneal fibroblasts was measured with assay kits. Surface expression of ICAM-1 on the cultured cells was measured with a whole-cell enzyme-linked immunosorbent assay. RESULTS. Lipopolysaccharide ( LPS) induced the release of the proinflammatory cytokine IL-6 and that of the chemokines G-CSF, MCP-1, MIP-1 beta, and IL-8 as well as surface expression of ICAM-1 by corneal fibroblasts, whereas IL-1 beta, TNF-alpha, and GMCSF were not detected in the culture supernatants of cells incubated with or without LPS. Triptolide and dexamethasone each inhibited in a concentration-dependent manner the LPS-induced release of IL-6, G-CSF, MCP-1, and IL-8 by corneal fibroblasts. Whereas the inhibitory effect of dexamethasone on LPS-induced IL-6 release was greater than that of triptolide, the inhibitory effect of triptolide on LPS-induced G-CSF release was more pronounced than was that of dexamethasone. Dexamethasone also inhibited LPS-induced MIP-1 beta release, whereas triptolide did not. Both compounds inhibited the LPS-induced surface expression of ICAM-1. CONCLUSIONS. Triptolide inhibits the LPS-induced expression of IL-6, chemokines ( G-CSF, MCP-1, IL-8), and ICAM-1 in cultured human corneal fibroblasts. This compound might thus be expected to limit the infiltration of immune cells into the cornea.